Add office photos
Employer?
Claim Account for FREE
AstraZeneca
4.0
based on 888 Reviews
Video summary
Company Overview
Company Locations
Working at AstraZeneca
Company Summary
AstraZeneca is a global, science-led biopharmaceutical business. Their innovative medicines are used by millions of patients worldwide.
Overall Rating
4.0/5
based on 888 reviews
3% above
industry average
Highly rated for
Work-life balance, Company culture, Salary
Critically rated for
Promotions
Work Policy
Hybrid
77% employees reported
Monday to Friday
66% employees reported
Flexible timing
75% employees reported
No travel
48% employees reported
View detailed work policy
Top Employees Benefits
Office cab/shuttle
109 employees reported
Free meal
107 employees reported
Health insurance
107 employees reported
Cafeteria
84 employees reported
View all benefits
About AstraZeneca
Founded in1999 (26 yrs old)
India Employee Count501-1k
Global Employee Count50k-1 Lakh
HeadquartersCambridge, Cambridgeshire, United Kingdom (UK)
Office Locations
--
Websiteastrazeneca.com
Primary Industry
Other Industries
Are you managing AstraZeneca's employer brand? To edit company information,
claim this page for free
View in video summary
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Report error
Managing your company's employer brand?
Claim this Company Page for FREE
AstraZeneca Ratings
based on 888 reviews
Overall Rating
4.0/5
How AmbitionBox ratings work?
5
433
4
267
3
95
2
32
1
61
Category Ratings
4.1
Work-life balance
4.0
Company culture
3.9
Salary
3.8
Job security
3.7
Skill development
3.7
Work satisfaction
3.3
Promotions
AstraZeneca is rated 4.0 out of 5 stars on AmbitionBox, based on 888 company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at AstraZeneca
based on 827 reviews
3.9
Rated by 197 Women
Rated 3.8 for Work-life balance and 3.8 for Company culture
4.1
Rated by 630 Men
Rated 4.2 for Work-life balance and 4.1 for Company culture
Work Policy at AstraZeneca
based on 103 reviews in last 6 months
Hybrid
77%
Work from office
23%
AstraZeneca Reviews
Top mentions in AstraZeneca Reviews
+ 5 more
Compare AstraZeneca with Similar Companies
 |  Change Company |  Change Company |  Change Company | |
|---|---|---|---|---|
Overall Rating | 4.0/5 based on 888 reviews | 3.9/5 based on 1.9k reviews | 4.1/5 based on 3.3k reviews  | 3.8/5 based on 1.4k reviews |
Highly Rated for | Work-life balance Company culture Salary | Work-life balance Company culture Skill development | Skill development Work-life balance Salary |  No highly rated category |
Critically Rated for | Promotions | Promotions | Promotions | Promotions |
Primary Work Policy | Hybrid 77% employees reported | Work from office 54% employees reported | Work from office 54% employees reported | Work from office 89% employees reported |
Rating by Women Employees | 3.9 Good rated by 197 women | 3.9 Good rated by 259 women | 4.0 Good rated by 417 women | 3.9 Good rated by 87 women |
Rating by Men Employees | 4.1 Good rated by 630 men | 4.0 Good rated by 1.5k men | 4.1 Good rated by 2.7k men | 3.8 Good rated by 1.2k men |
Job security | 3.8 Good | 3.4 Average | 3.8 Good | 3.7 Good |
View more
AstraZeneca Salaries
AstraZeneca salaries have received with an average score of 3.9 out of 5 by 888 employees.
Senior Consultant
(468 salaries)
Unlock
₹12 L/yr - ₹50 L/yr
Territory Business Manager
(217 salaries)
Unlock
₹3.4 L/yr - ₹12.5 L/yr
Associate Engineer
(200 salaries)
Unlock
₹3.7 L/yr - ₹9.9 L/yr
Senior Engineer
(145 salaries)
Unlock
₹8 L/yr - ₹31 L/yr
Key Account Manager
(133 salaries)
Unlock
₹5.5 L/yr - ₹20 L/yr
Analyst
(125 salaries)
Unlock
₹6.6 L/yr - ₹24 L/yr
Clinical Research Associate
(91 salaries)
Unlock
₹4 L/yr - ₹10.5 L/yr
Software Engineer
(88 salaries)
Unlock
₹4.7 L/yr - ₹15.9 L/yr
Lead Consultant
(73 salaries)
Unlock
₹20 L/yr - ₹50 L/yr
Junior Associate
(72 salaries)
Unlock
₹4 L/yr - ₹10 L/yr
AstraZeneca Interview Questions
A Senior Consultant was asked 3mo agoQ. What is SCD and what are the different types of SCD?
A Reporting Analyst was asked Q. Describe your experience with Workday, specifically in creating calcul...read more
A Digital Marketer was asked 9mo agoQ. Explain the best sorting technique.
A QA was asked Q. What is your role in QA?
A Graduate Trainee was asked Q. What is the difference between heap and stack memory in Java?
AstraZeneca Jobs
Popular Designations AstraZeneca Hires for
Popular Skills AstraZeneca Hires for
Current Openings
AstraZeneca News
View all
Rajeev Samuel Devadas: Pioneering Leadership in Cloud Modernization
- Rajeev Samuel Devadas is a prominent figure in cloud modernization and application migration with over 19 years of experience, currently serving as Application Consultant Architect at IBM.
- He holds various certifications from IBM, Microsoft, and AWS, shaping his technical expertise and analytical problem-solving approach.
- Rajeev began his career at IBM India in 2005, leading data center migrations for global clients like AstraZeneca, Novartis, Royal Bank of Scotland, and National Australia Bank.
- He later moved to Alphavista Services Inc. in 2015 and then rejoined IBM in the U.S. in 2017, where he led application modernization efforts for clients like Citi, Kaiser Permanente, CIBC Bank, SONY Electronics, and JC Penny.
- Rajeev's leadership style blends technical expertise with visionary thinking, guiding teams through successful transitions without service disruptions.
- His achievements include the 2020 Innovation and Delivery Excellence award, introducing Gen AI-led Application Assessment, and winning multiple IBM accolades and challenges.
- Rajeev contributes to academic and professional discussions on cloud modernization, presenting at IBM events and bridging theoretical frameworks with practical implementation.
- He continues to drive innovations in hybrid cloud architecture, data center modernization, and AI-integrated cloud assessment models, empowering teams for digital transformation challenges.
- Rajeev mentors architects at IBM's global delivery centers and refines modernization methodologies to align with business goals and regulatory requirements.
- As a thought leader, Rajeev shapes how enterprises adopt emerging technologies and optimize cloud investments, redefining the future of enterprise IT globally.
TechBullion | 20 Jun, 2025
Ericsson: Optus 5G Antennas, Cloud-Native Core with Google Cloud, Sweden AI Factory and More
- Ericsson is driving global 5G innovation through various initiatives, including deploying antennas for Optus 5G network in Australia for improved performance and energy efficiency.
- They launched Ericsson On-Demand, a SaaS platform on Google Cloud, assisting CSPs in setting up core network services quickly and cost-effectively.
- Ericsson won the Network Sustainability Award for its 5G Advanced Automated Energy Saver and established a collaboration with Supermicro for Edge AI deployment.
- They extended their partnership with Carleton University in Canada for advancing 5G wireless networks and deployed a private 5G network in Istres, France.
- Ericsson and Telstra introduced a Triple-Band FDD Massive MIMO 5G Radio, enhancing coverage and capacity across Australia.
- They joined a consortium to develop the Swedish AI Factory with partners like AstraZeneca and SEB, aiming to accelerate AI innovation in Sweden.
- Ericsson plans to expand R&D investment in Japan, creating up to 300 high-skilled telecom jobs to enhance advanced business applications like AI.
- Additionally, they launched an Indoor 5G Solution developed in Canada, catering to small businesses with multi-gigabit speeds and improved connectivity.
Telecomtalk | 13 Jun, 2025
Databricks Introduces Agent Bricks to Build Production-Ready AI Agents on Enterprise Data
- Databricks introduced Agent Bricks at the Data + AI Summit for building and deploying AI agents using enterprise data.
- Agent Bricks automates AI agent development by transforming task descriptions and data into deployable agents.
- The system uses synthetic data and benchmarks to optimize agent performance based on accuracy and cost tradeoffs.
- Use cases include Information Extraction Agent, Knowledge Assistant Agent, Multi-Agent Supervisor, and Custom LLM Agent.
- Agent Bricks addresses challenges in AI development by providing domain-specific evaluations and a streamlined workflow.
- AstraZeneca and Flo Health are early adopters seeing positive results with Agent Bricks in data extraction and accuracy improvements.
- Databricks also launched serverless GPU support and MLflow 3.0 to enhance AI system management.
- MLflow 3.0 includes features for generative AI like prompt management and integration with data lakehouses.
- The combination of Agent Bricks, serverless GPUs, and MLflow 3.0 positions Databricks as a comprehensive platform for enterprise AI systems.
Analyticsindiamag | 12 Jun, 2025
I attended the world's biggest cancer conference. Doctors gave standing ovations to 2 major breakthroughs.
- The American Society of Clinical Oncology (ASCO) annual meeting in Chicago showcased groundbreaking cancer research, including a study showing exercise outperforming chemotherapy for colon cancer patients.
- A methodically-prescribed exercise routine significantly reduced cancer recurrence and deaths compared to standard advice, providing a 7% survival boost.
- The study emphasized the need for personalized exercise programs akin to drug prescriptions for sustained behavior change.
- AstraZeneca's immunotherapy drug, Imfinzi, showed promising results in boosting gastric cancer patients' survival rates, marking a significant advancement in cancer treatment.
- The conference highlighted the trend of utilizing early immune therapy treatments that could replace or complement traditional cancer treatments, improving outcomes and reducing side effects.
- The focus on early disease treatment with immunotherapy is seen as a way to increase the chances of cure and reduce long-term side effects compared to traditional treatments.
Insider | 11 Jun, 2025
Q4 Earnings Impact: Vodafone Idea, Apollo Hospitals Shares Rise; Nykaa, Titagarh Rail Fall Nearly 3%
- Shares of Vodafone Idea, Apollo Hospitals rose following their Q4 results, while Nykaa and Titagarh Rail shares declined.
- Vodafone Idea reported a 0.72% rise in shares to Rs 6.97, with a 1% revenue decline to Rs 11,013 crore.
- Apollo Hospitals saw a 2.39% increase in shares to Rs 7,045, with a 13.1% revenue hike to Rs 5,592.20 crore.
- Nykaa's parent, FSN E-Commerce Ventures, experienced a stock fall by nearly 3%, alongside Titagarh Rail.
- Key highlights included AstraZeneca Pharma's 8.69% share rise, with revenue up 25.3% and net profit up 47.5%.
- Purvankara Ltd. saw the most significant fall in shares by 9.98%, with weak revenue and Ebitda performance.
- Inox Wind reported a revenue rise to Rs 1,248 crore, while Nykaa's revenue grew by 23.63% in Q4.
- TCPL Packaging observed a 6.42% share decline, despite an increase in net profit, and shares of Jamna Auto decreased.
- Titagarh Rail Systems faced a revenue decline of 4.5% and a 15.3% drop in Ebitda, while Genus Power Infrastructures showed notable growth.
- Greenlam Industries' revenue increased by 9.2%, but Ebitda declined, and Easy Trip Planners reported decreased revenue and net profit.
Bloomberg Quint | 2 Jun, 2025
Stock Market Today: All You Need To Know Going Into Trade On June 2
- The benchmark equity indices closed lower on Friday, with the NSE Nifty 50 ending 0.33% lower and BSE Sensex ending 0.22% lower.
- Foreign portfolio investors turned net sellers of Indian equities, while domestic institutional investors remained net buyers.
- Stocks in focus included Infosys, Indian Oil Corp, Vedanta, Cipla, Adani Energy Solutions, Canara Bank, and more.
- Earnings post-market hours included updates from Vodafone Idea, Apollo Hospitals, AstraZeneca Pharma, Inox Green, Puravankara, SUN TV, and others.
- IPO offerings from companies like Aegis Vopak Terminals and Schloss Bangalore, along with block deals and bulk deals, were highlighted.
- Trading tweaks, F&O cues, major updates in currency values, and other news related to the stock market were also covered.
Bloomberg Quint | 2 Jun, 2025
Stocks To Watch Today: Bajaj Auto, Suzlon Energy, Mazagon Dock, Castrol India, Ola Electric
- Stocks to watch today include Bajaj Auto, Suzlon Energy, Mazagon Dock, Castrol India, and Ola Electric, along with NLC, Rail Vikas Nigam, and SJVN.
- Castrol India issued a clarification regarding media reports on BP's lubricant business, while Cipla incorporated a subsidiary in Germany and Wipro unveiled its Global Innovation Network.
- Companies like UltraTech Cement, Allcargo Logistics, Himadri Speciality Chemical, Rail Vikas Nigam, and Piramal Enterprises also made significant updates.
- Earnings highlights for Bajaj Auto, Suzlon Energy, Mazagon Dock, SJVN, and other companies show revenue and profit variations with some widening losses.
- Ola Electric reported a significant decrease in revenue and widened losses in its Q4 earnings report.
- Other companies such as Sobha, ICRA, Amara Raja, Procter & Gamble Health, Lemon Tree, and many more also showcased their financial performances in the latest quarter.
- Watchlists for the day include various companies across different sectors like Apollo Hospitals Enterprise, AstraZeneca Pharma India, Genesys International Corporation, and more as their earnings are in focus.
- The stock market updates and latest news can be followed on NDTV Profit for real-time information on trade activities and performances of different companies.
- A wide range of companies are showing varied results in their financial performances, signaling the overall market dynamics and sectoral trends.
- Stay informed with the latest business updates and market movements to make informed investment decisions and track the performance of specific stocks mentioned.
Bloomberg Quint | 30 May, 2025
What Is Alibaba Cloud? Services, Uses, Benefits & Challenges Explained
- Alibaba Cloud is a public cloud computing platform offering services like IaaS, PaaS, SaaS, FaaS, and CaaS, primarily dominant in China and APAC region.
- Investment in AI and machine learning with products like Qwen LLM series demonstrates its focus on emerging technologies.
- Alibaba Cloud, founded in 2009, is known for its diverse cloud services catering to various industries globally.
- Services offered include IaaS, PaaS, SaaS, CaaS, and FaaS, with popular products like ECS, OSS, EBS, Function Compute, and ACK.
- Key benefits of Alibaba Cloud include scalability, competitive pricing, extensive service catalog, and focus on emerging technologies.
- Challenges involve language barriers, compliance complexities, and concerns over data privacy and government access.
- Competitors include AWS, Azure, Google Cloud, IBM Cloud, Salesforce, Oracle Cloud, Tencent Cloud, Huawei Cloud, and Baidu AI Cloud.
- Future plans include increasing AI investments, global infrastructure expansion, and partnerships for growth.
- Alibaba Cloud's strengths lie in AI innovation, scalability, competitive pricing, and service offerings, positioning it as a strong contender in the cloud computing market.
- Companies like Duolingo, Ford, Sephora, AstraZeneca, and HP China are among those using Alibaba Cloud for their cloud computing needs.
Cloudwards | 29 May, 2025
AstraZeneca gets CDSCO nod for lung cancer drug
- AstraZeneca has secured approval from CDSCO for Osimertinib tablets in the strength of 40mg and 80mg.
- The approval is for Osimertinib as monotherapy to treat patients with locally advanced, unresectable non-small cell lung cancer.
- The new indication makes Osimertinib the first-in-class treatment option for EGFR-mutated NSCLC post-chemoradiation.
- AstraZeneca Pharma India's President highlighted the significance of this approval in redefining lung cancer treatment in India.
HinduBusinessLine | 29 May, 2025
Swedish Industry Giants Unite to Build Nation’s Largest AI Supercomputer
- Swedish corporations Ericsson, AstraZeneca, Saab, SEB, and Wallenberg Investments AB have joined forces to create a national AI facility with a focus on high-performance computing.
- The initiative will feature two Nvidia DGX SuperPODs equipped with Grace Blackwell GB300 systems, making it Sweden's largest AI supercomputer upon completion.
- The facility will support various AI tasks, such as training industry-specific models and large-scale inference, while Nvidia plans to establish its first AI Technology Centre in Sweden to bolster local research endeavors.
- The collaboration aims to leverage AI for innovation and commercial growth, with specific applications in areas like network technology, drug discovery, defense systems, and customer services, highlighting the interplay between AI, 5G, and future technological advancements.
VoIP | 28 May, 2025
Powered by
AstraZeneca Offices
Compare AstraZeneca with
Sanofi
4.2
Unichem Laboratories
3.8
Piramal Pharma
4.0
Strides Pharma
3.9
Natco Pharma
4.0
Shilpa Medicare
3.5
Eris Lifesciences
3.7
Flamingo Pharmaceuticals
3.2
Novartis Healthcare
4.1
Marksans Pharma
3.2
Concord Biotech
3.8
Bliss Gvs Pharma
4.1
Gufic Biosciences
3.4
Caplin Point Laboratories
3.7
Sami-Sabinsa Group
3.0
Kwality Pharmaceuticals
3.8
SMS Pharmaceuticals
3.5
SAVA Healthcare
3.7
Kopran
3.6
SeQuent Scientific
3.7
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to AstraZeneca
Granules India Limited
Manufacturing, Pharma
3.8
• 1.4k reviews
Sanofi
Biotech & Life sciences, Manufacturing, Analytics & KPO, Pharma
4.2
• 1.3k reviews
Unichem Laboratories
Pharma
3.8
• 1.2k reviews
Piramal Pharma
Biotech & Life sciences, Pharma
4.0
• 1.2k reviews
Strides Pharma
Pharma
3.9
• 988 reviews
Natco Pharma
Manufacturing, Pharma
4.0
• 827 reviews
Shilpa Medicare
Pharma
3.5
• 753 reviews
Eris Lifesciences
Manufacturing, Pharma
3.7
• 711 reviews
Flamingo Pharmaceuticals
Manufacturing, Pharma
3.2
• 416 reviews
Novartis Healthcare
Manufacturing, Analytics & KPO, Pharma
4.1
• 374 reviews
AstraZeneca FAQs
When was AstraZeneca founded?
AstraZeneca was founded in 1999. The company has been operating for 26 years primarily in the Pharma sector.
Where is the AstraZeneca headquarters located?
AstraZeneca is headquartered in Cambridge, Cambridgeshire.
How many employees does AstraZeneca have in India?
AstraZeneca currently has more than 900+ employees in India. Engineering - Software & QA department appears to have the highest employee count in AstraZeneca based on the number of reviews submitted on AmbitionBox.
Does AstraZeneca have good work-life balance?
AstraZeneca has a work-life balance rating of 4.1 out of 5 based on 800+ employee reviews on AmbitionBox. 79% employees rated AstraZeneca 4 or above on work-life balance. This rating reflects the company's efforts to help employees maintain a healthy balance between their personal and professional lives. We encourage you to read AstraZeneca work-life balance reviews for more details.
Is AstraZeneca good for career growth?
Career growth at AstraZeneca is rated as moderate, with a promotions and appraisal rating of 3.3. 21% employees rated AstraZeneca 3 or below, while 79% employees rated it 4 or above on promotions / appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading AstraZeneca promotions / appraisals reviews for more detailed insights.
What are the pros and cons of working in AstraZeneca?
Working at AstraZeneca comes with several advantages and disadvantages. It is highly rated for work life balance, company culture and salary & benefits. However, it is poorly rated for promotions / appraisal, work satisfaction and skill development, based on 800+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Trusted by over 1.5 Crore job seekers to find their right fit company
80 Lakh+
Reviews
10L+
Interviews
4 Crore+
Salaries
1.5 Cr+
Users
Contribute to help millions
AmbitionBox Awards
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2025 Info Edge (India) Ltd.
Follow Us
